Side-by-side comparison of AI visibility scores, market position, and capabilities
US YC W20 credit-building debit card reporting to all 3 bureaus without debt risk for 150K+ users; competing with Chime Credit Builder and Self Financial for the 100M+ Americans with thin-file or subprime credit seeking FICO score improvement.
Grain is a United States-based credit-building fintech platform — backed by Y Combinator (W20) — providing 150,000+ users with a credit-building debit card that converts everyday debit card purchases into credit-building activity reported to all three major credit bureaus (Equifax, Experian, TransUnion), enabling consumers to build or rebuild credit scores without taking on traditional credit card debt or risk. Founded in 2017, Grain serves the estimated 100+ million Americans who are credit-invisible (no credit score), thin-file (insufficient credit history), or rebuilding from past credit damage — all of whom are excluded from mainstream credit products, face higher interest rates on loans, and experience barriers to renting apartments or getting job offers where credit checks are required.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.